McKesson and CD&R near $5bn-plus deal to buy infusion services provider
AI Summary
McKesson, in partnership with CD&R, is close to finalizing a deal worth over $5 billion to acquire Option Care Health, a prominent infusion services provider. This acquisition highlights a growing trend where private equity firms identify and capitalize on undervalued healthcare services companies. The move underscores the sector's potential for significant returns and could reshape the landscape of infusion services, offering improved care and operational efficiencies to patients nationwide.
Original Source
Read the full article at Ft →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.